UK markets closed

NexgenRx Inc. (NXG.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.22000.0000 (0.00%)
As of 03:11PM EDT. Market open.
Currency in CAD

Valuation measures4

Market cap (intra-day) 15.52M
Enterprise value 15.75M
Trailing P/E 6.98
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.12
Price/book (mrq)2.56
Enterprise value/revenue 1.14
Enterprise value/EBITDA 15.27

Trading information

Stock price history

Beta (5Y monthly) 0.23
52-week change 3-31.25%
S&P500 52-week change 325.77%
52-week high 30.3200
52-week low 30.1800
50-day moving average 30.2240
200-day moving average 30.2473

Share statistics

Avg vol (3-month) 39.27k
Avg vol (10-day) 32.1k
Shares outstanding 570.53M
Implied shares outstanding 670.53M
Float 844.66M
% held by insiders 136.63%
% held by institutions 10.00%
Shares short (30 Apr 2024) 4277
Short ratio (30 Apr 2024) 40.01
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 40.00%
Shares short (prior month 28 Mar 2024) 41.04k

Dividends & splits

Forward annual dividend rate 40.01
Forward annual dividend yield 44.55%
Trailing annual dividend rate 30.01
Trailing annual dividend yield 34.55%
5-year average dividend yield 4N/A
Payout ratio 423.26%
Dividend date 304 Jan 2024
Ex-dividend date 428 Dec 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -2.40%
Operating margin (ttm)-7.06%

Management effectiveness

Return on assets (ttm)-0.32%
Return on equity (ttm)-4.01%

Income statement

Revenue (ttm)13.85M
Revenue per share (ttm)0.20
Quarterly revenue growth (yoy)5.70%
Gross profit (ttm)N/A
EBITDA 1.1M
Net income avi to common (ttm)-331.97k
Diluted EPS (ttm)-0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.88M
Total cash per share (mrq)0.03
Total debt (mrq)461.88k
Total debt/equity (mrq)5.99%
Current ratio (mrq)1.06
Book value per share (mrq)0.09

Cash flow statement

Operating cash flow (ttm)1.28M
Levered free cash flow (ttm)1.32M